NCT01528241View on ClinicalTrials.gov

Characterize the Regional Distribution of [11C] ABP688 in Brain by Positron Emission Tomography (PET)

PHASE1CompletedINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

August 31, 2008

Primary Completion Date

May 31, 2010

Study Completion Date

May 31, 2010

Conditions
Depression
Interventions
DRUG

ABP688

Carbon 11 labeled ABP688 will be administered intravenously as a slow intravenous push.

Trial Locations (2)

Unknown

Novartis Investigative Site, New York

Novartis Investigative Site, Pittsburgh

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY